CPP 2nd Dose Program

CPP member practices can earn an educational grant up to $1,000! It’s as easy as 1, 2, 3...

The CPP 2nd Dose Program provides an opportunity to examine your practice's 2nd dose immunization rates for meningococcal ACWY, HPV, and adult pneumococcal, access resources to help implement a strategy in your office to raise those rates and share successful strategies with other CPP members.

Click here to see why attention to these vaccines is needed.

U.S. Adolescents / Teens U.S. Adults
MenACWY
1st Dose
MenACWY
2nd Dose
MenB
1st Dose
MenB
2nd Dose
HPV
1st Dose
HPV
≥ 2 Doses
Prevnar 13
1st Dose
Pneumovax 23
2nd Dose
79% 28% *NEW Category B Recommendation 51% 41% *NEW Recommendation

2014 Stats: http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6429a3.htm

  • MenACWY 2nd dose recommendation since 2005: 1st dose at 11-12 years; 2nd dose at 16 years (Ohio school requirement of 2 doses for students entering 12th grade effective fall 2016.)
  • NEW Category B Recommendation for MenB in 2016: 0 & 6 months (Trumenba) or 0 & 1 month (Bexsero) for patients 16-18 years old.
  • HPV 2-dose series recommended: 0 & 6 months for all patients under 15 years
  • NEW Adult Pneumococcal Recommendation in 2014: one dose of Prevnar 13 followed at least 12 months later by one dose of Pneumovax 23 for all adults 65 and older.

All grant submissions must be received by June 30, 2018. Multi-site groups or networks must submit grant applications separately. For any questions, please contact the CPP office at or 877-277-9330.